Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Viking Therapeutics (VKTX) Amortization - Intangibles (2016 - 2018)

Viking Therapeutics (VKTX) has disclosed Amortization - Intangibles for 5 consecutive years, with $146000.0 as the latest value for Q2 2018.

  • For Q2 2018, Amortization - Intangibles fell 56.68% year-over-year to $146000.0; the TTM value through Mar 2019 reached $146000.0, down 86.85%, while the annual FY2018 figure was $404000.0, 68.51% down from the prior year.
  • Amortization - Intangibles hit $146000.0 in Q2 2018 for Viking Therapeutics, down from $258000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $524977.0 in Q2 2016 and bottomed at $6379.0 in Q1 2014.
  • Average Amortization - Intangibles over 5 years is $273697.2, with a median of $257000.0 recorded in 2017.
  • Year-over-year, Amortization - Intangibles soared 2595.64% in 2015 and then plummeted 56.68% in 2018.
  • Viking Therapeutics' Amortization - Intangibles stood at $294310.0 in 2014, then dropped by 18.28% to $240516.0 in 2015, then soared by 79.29% to $431227.0 in 2016, then tumbled by 39.94% to $259000.0 in 2017, then crashed by 43.63% to $146000.0 in 2018.
  • According to Business Quant data, Amortization - Intangibles over the past three periods came in at $146000.0, $258000.0, and $259000.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.